Dr. Danoff is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and Co-Director of the Hopkins Interstitial Lung Disease Clinic. She is a specialist in diseases causing fibrosis or scarring in the lung, particularly those associated with autoimmune diseases including myositis. Dr. Danoff is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, Endoscopy, and Lung Transplant.

Dr. Wise is a pulmonary, critical care physician. He is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. He is a consultant for patients with scleroderma and interstitial lung disease. He has expertise in pulmonary physiology and lung function testing. Dr. Wise’s research focus is the conduct of multi-center clinical trials in airway diseases and related translational research. Dr. Wise is the co-director of the Pulmonary T32 Multi-disciplinary Training Program in Pulmonary Disease. Dr. Wise is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Systemic Sclerosis (SSc), Interstitial Lung Disease, Acute Interstitial Pneumonia, and Sarcoidosis.

Mark Gosnell is a Pulmonary Medicine specialist and a Sleep Medicine provider in Baltimore, Maryland. Dr. Gosnell is rated as a Distinguished provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Lung Metastases, Obstructive Sleep Apnea, Chronic Obstructive Pulmonary Disease (COPD), Gastrostomy, and Endoscopy. Dr. Gosnell is currently accepting new patients.

Dr. McCormack is a pulmonary, critical care physician and Associate Director of the Pulmonary & Critical Care Medicine Division. She is an expert in the diagnosis and treatment of patients with obstructive lung disease, including those with asthma and COPD. She has expertise in pulmonary physiology. She serves as the Medical Director of the Johns Hopkins University Pulmonary Function Laboratory and as the Chair of the American Thoracic Society Pulmonary Function Test Committee. She earned her M.D. from Jefferson Medical College of Thomas Jefferson University and her M.H.S. from the Bloomberg School of Public Health. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. She was the recipient of the Frederick L. Brancati Excellence in Mentoring Award. She plays an active role in mentoring fellows and junior faculty in the Pulmonary & Critical Care Medicine Division. Dr. Mccormack is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Asthma, Acute Interstitial Pneumonia, Interstitial Lung Disease, and Lung Transplant.

Dr. Chen practices Pulmonary and Critical Care Medicine. His primary area of interest is sarcoidosis, and he has extensive experience in the diagnosis and treatment of sarcoidosis in all of its forms, and the management of consequences of this systemic disease. The Sarcoidosis Clinic often serves to coordinate management of patients with multi-organ involvement with sarcoidosis, and to this end Dr. Chen actively maintains clinical and research collaborations with Cardiology, Cardiovascular Nuclear Medicine, Neurology, and Ophthalmology. Additionally, Dr. Chen participates as a Physician Champion in the Johns Hopkins Health System Epic project to improve the safety and quality of care of critically ill patients through optimization of the electronic medical record. His work involves developing systems-based approaches to complex management issues, including sepsis and severe alcohol withdrawal. Dr. Chen is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, and Acute Interstitial Pneumonia.

Dr. Liu is a pulmonary physician with additional expertise in allergy and immunology. He is an expert in the diagnosis and treatment of patients with severe asthma with a focus on developing new treatments for severe disease that has failed to respond to standard therapies. Dr. Liu is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Eosinophilic Asthma, Chronic Eosinophilic Pneumonia, Eosinophilic Pneumonia, Simple Pulmonary Eosinophilia, and Gastrostomy.

Dr. Gregory Diette is a professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in the Department of Epidemiology in the Johns Hopkins Bloomberg School of Public Health. He has over 20 years of experience diagnosing and managing complex and challenging pulmonary conditions. He is expert in the diagnosis and treatment of patients with common conditions such as asthma and COPD, as well as uncommon conditions such as allergic bronchopulmonary aspergillosis (ABPA), bronchiolitis obliterans, hypersensitivity pneumonitis and others. His practice includes evaluation of patients with unexplained shortness of breath and cough as well as patients with a variety of environmental lung conditions. In addition to his outpatient practice, Dr. Diette provides inpatient care on the pulmonary, critical care and internal medicine services. Dr. Diette earned his M.D. from the Temple University School of Medicine. He completed his residency at the Hospital of the University of Pennsylvania and performed a fellowship in pulmonary and critical care medicine at Johns Hopkins. He received his M.H.S. from the Johns Hopkins Bloomberg School of Public Health. His research interests include environmental impacts on lung disease, epidemiology of airway disease and chronic obstructive pulmonary disease. Dr. Diette is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Asthma, Allergic Bronchopulmonary Aspergillosis, Pulmonary Aspergilloma, and Aspergillosis.

Dr. Sarath Raju is an instructor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include obstructive lung diseases (asthma, chronic obstructive pulmonary disease), chronic lung disease in persons living with HIV, and critical care medicine. Dr. Raju earned his M.D. from Rush Medical College. He completed his residency at Johns Hopkins, where he also performed a fellowship in pulmonary and critical care medicine. He previously served as an Assistant Chief of Service for the Osler Medical Housestaff Training Program at Johns Hopkins. Dr. Raju joined the Johns Hopkins faculty in 2020, and is supported by the NIH to conduct research investigating the intersection of HIV, environmental exposures, and lung health. Dr. Raju is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Bronchogenic Cyst, Lung Metastases, Bronchitis, and Endoscopy.

Jonathan Rich is a primary care provider, practicing in Internal Medicine in Baltimore, Maryland. Dr. Rich is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Heart Failure, Hypertension, Type 2 Diabetes (T2D), Heart Transplant, and Lung Transplant.

Dr. Buescher is a pulmonary critical care physician. He has been deeply involved in clinical teaching of both medical students, interns, residents and fellows throughout his career. He is the director of the Medical/Surgical Critical Care Units at MedStar Union Memorial Hospital as well as MedStar Good Samaritan Hospital. He is president of a large community private practice pulmonary and critical group (Pulmonary and Critical Care Associates of Baltimore) He serves at Hopkins on the part-time clinical faculty. Research Summary Dr. Buescher is involved in multiple clinical research projects. Dr. Buescher is rated as an Advanced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Sarcoidosis, Neurosarcoidosis, Lung Metastases, Endoscopy, and Gastrostomy.

Swati D Phatak, M.D., practices internal medicine at Johns Hopkins Community Physicians Greater Dundalk. She received her medical degree from Topiwala National Medical College in Mumbai, India. Dr. Phatak completed residencies at Grant Medical College University of Mumbai and at State University of New York Upstate Medical University in Syracuse, New York. She speaks English, Hindi and Marathi. Dr. Phatak is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Vitamin D Deficiency, Hypertension, Familial Hypertension, and Glucocorticoid-Remediable Aldosteronism.

Dr. Galiatsatos is a pulmonary and critical care medicine physician. He is an expert in the diagnosis and treatment of obstructive lung disease, tobacco cessation, and in the care of critically ill patients in the Medical ICU. He is a member of the Obstructive Lung Disease Group at Johns Hopkins, oversees the Tobacco Treatment Clinic and provides teaching to medical students and residents at Johns Hopkins. Dr. Galiatsatos is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), COVID-19, Severe Acute Respiratory Syndrome (SARS), and Pneumonia.

Dr. Hansel is a pulmonary and critical care medicine physician. She is an expert in the diagnosis and treatment of obstructive airway diseases, including asthma and chronic obstructive pulmonary disease (COPD), and care of patients in the Medical ICU. Dr. Hansel is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Asthma, Bronchitis, and Endoscopy.

Dr. Belz is a specialist in Pulmonary and Critical Care Medicine. He is Director of Bronchiectasis at the Johns Hopkins Center for Nontuberculous Mycobacteria and Bronchiectasis. He is an expert in the care of patients with bronchiectasis, asthma, COPD, and NTM pulmonary disease, and in the care of critically ill patients in the ICU. His research is dedicated to decreasing health disparities in the treatment of obstructive lung diseases such as COPD and bronchiectasis. He participates in clinical trials researching new treatments for bronchiectasis and NTM lung disease. He provides teaching to medical students, residents, and fellows at Johns Hopkins. Dr. Belz is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Bronchiectasis, Lung Metastases, Cystic Fibrosis, and Allergic Bronchopulmonary Aspergillosis.

Matthew Lammi, MD MSCR is an Associate Professor of Medicine and part of the Interstitial Lung Disease (ILD) Program. Dr. Lammi obtained his medical degree from Temple University School of Medicine and did his internal medicine, pulmonary, and critical care training at Temple University Hospital. He then joined the faculty at LSU in New Orleans, where he served as the Director of the Comprehensive Pulmonary Hypertension Center. He joined Johns Hopkins in 2023. He currently serves as the Associate Director of the Johns Hopkins Pulmonary Fibrosis Foundation Care Center and is the Associate Program Director for the Advanced Lung Disease Fellowship. His research focuses on the intersection between ILD and pulmonary hypertension, particularly in patients with systemic sclerosis. He is currently a co-Principal Investigator for a clinical trial of therapy for scleroderma associated pulmonary hypertension supported by the Department of Defense Peer Reviewed Medical Research Program. He is active in numerous societies and serves as the Chair of the Research Committee for the Pulmonary Hypertension Association. Dr. Lammi is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Pulmonary Hypertension, Sarcoidosis, Systemic Sclerosis (SSc), Interstitial Lung Disease, and Lung Transplant.

Dr. Neptune is a pulmonary, critical care physician with expertise in genetic disorders of the matrix with pulmonary manifestations. She is also skilled in the management of patients with advanced obstructive lung disease, especially emphysema. Dr. Neptune has extensive expertise in the diagnosis and management of the pulmonary complications of Marfan Syndrome, Loeys-Dietz Syndrome, vascular Ehlers Danlos Syndrome and other matrix disorders and serves on the Professional Advisory Board of the Marfan Foundation. She is also an expert on tobacco dependence and is the Vice-Chair of the Tobacco Action Committee of the American Thoracic Society. Dr. Neptune earned her M.D. from Harvard Medical School. She completed her residency and performed a fellowship in pulmonary and critical care at the University of California, San Francisco. She also performed a fellowship in genetics at Johns Hopkins. Her research interests include therapeutic strategies in Marfan syndrome; mechanisms and prevention of progression of COPD; and hepatocyte growth factor signaling in airspace homeostasis. Dr. Neptune is committed to creating a diverse research community and clinical workforce. She is involved in multiple diversity initiatives at Johns Hopkins and the American Thoracic Society. She is also involved in increasing awareness of tobacco dependence and the needed regulatory policies. Dr. Neptune serves on the Compliance Compensation Subcommittee for the Department of Medicine. Dr. Neptune is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Eosinophilic Granulomatosis with Polyangiitis (EGPA, Churg-Strauss Syndrome), Acute Interstitial Pneumonia, Interstitial Lung Disease, and Emphysema.

Dr. Fawzy is a pulmonary and critical care physician. He is an expert in the diagnosis and treatment of lung disease with a particular focus on asthma and COPD (emphysema and chronic bronchitis) and in the care of critically ill patients in the Medical ICU. Dr. Fawzy earned his M.D. from Stony Brook University. He completed his residency at Boston University Medical Center and fellowship in pulmonary and critical care medicine at Johns Hopkins University. Dr. Fawzy joined the Johns Hopkins faculty in 2020, and is supported by the NIH to conduct clinical and translational research investigating the role of platelet phenotypes in COPD. Dr. Fawzy is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Cerebral Hypoxia, Emphysema, and Bronchitis.

Dr. Agee is medical director for the Bayview Medical Offices. Her practice includes all aspects of primary care medicine, including prevention, pap smears and cortisone shots. Dr. Agee is from Annapolis. She attended Wake Forest University School of Medicine, in North Carolina, trained in general internal medicine at Johns Hopkins Bayview Medical Center. Dr. Agee is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, and Type 2 Diabetes (T2D).

Anna Gersten is a Pulmonary Medicine provider in Baltimore, Maryland. Dr. Gersten is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Interstitial Lung Disease, Acute Interstitial Pneumonia, Pulmonary Fibrosis, and Lung Metastases.

Dr. Cynthia Boyd is Professor of Medicine at the Johns Hopkins University School of Medicine. Dr. Boyd is the Director, Division of Geriatric Medicine and Gerontology. She holds a joint appointment in Health Policy and Management and Epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Boyd is a core faculty member at the Center for Transformative Geriatric Research, Johns Hopkins Center on Aging and Health and the Roger and Flo Lipitz Center to Advance Policy in Aging and Disability. A former Robert Wood Johnson Physician Faculty Scholar and a Beeson Scholar, Dr. Boyd is trained in internal medicine, geriatric medicine and epidemiology. Dr. Boyd’s career has focused on improving the health and well-being of older adults with multiple chronic conditions, with robust research and mentoring programs that have helped launch the careers of multiple junior faculties, fellows, medical students and other learners. She earned her M.D. from the Duke University School of Medicine and her M.P.H. from the University of North Carolina at Chapel Hill. She completed her residency at Johns Hopkins Hospital and performed a fellowship in geriatric medicine at Johns Hopkins Bayview Medical Center. Dr. Boyd has been recognized with several honors, including the American Geriatric Society’s Outstanding Scientific Achievement for Clinical Investigation Award, election to the American Society for Clinical Investigation, and Fellowship in the American College of Physicians and the American Geriatric Society. Her research has been funded by the NIH, AHRQ, PCORI, and foundations. Dr. Boyd is rated as an Experienced provider by MediFind in the treatment of Lung Metastases. Her top areas of expertise are Brittle Cornea Syndrome, Vascular Ehlers-Danlos Syndrome (VEDS), Musculocontractural Ehlers-Danlos Syndrome (mcEDS), and Ehlers-Danlos Syndrome (EDS).